John L. Colombo
VenatoRx Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Neonatal Respiratory Health Research, Tracheal and airway disorders
Most-Cited Works
- → Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial(2017)293 cited
- → Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial(2007)269 cited
- → Recurrent aspiration in children: Lipid‐laden alveolar macrophage quantitation(1987)177 cited
- → Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis(1995)77 cited
- → Pulmonary aspiration and lipid-laden macrophages: In search of gold (standards)(1999)56 cited
- → Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study(2021)51 cited